EHA 2016 | Killer antibodies against AML
Press brief by Mette Hazenberg, MD, PhD of the Academic Medical Center, Amsterdam, Netherlands, at the 2016 Annual Meeting of the European Association of Hematology (EHA), held in Copenhagen, Denmark.
Get great new content delivered to your inboxSign up
An exciting era for CAR T-cell therapy
Molecular techniques for monitoring MRD in AML
NGS: a valuable tool for elucidating the genetic landscape of AML
Understanding the biology behind AML relapse
FLT3 inhibitors as a strategy to treat AML